Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2006 / Cilt: 40 - Sayı: 4

Dramatic response of the topical imiquimod treatment in genital warts: Two children cases

Topikal imikimod tedavisinde dramatik yanıt veren kandiloma aküminata: İki çocuk olgu sunumu

Pages
142–144
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report herein two children of condyloma acuminata cases that have responded dramatically to topically applied imiquimod.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Imiquimod is an immunomodulating agent that is reported to be effective and is approved for the topical treatment of external anogenital warts.
📊
Key Findings & Data:However there are few studies on its usage in children.
💡
Conclusion & Impact:We report herein two children of condyloma acuminata cases that have responded dramatically to topically applied imiquimod.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Imiquimod is an immunomodulating agent that is reported to be effective and is approved for the topical treatment of external anogenital warts. However there are few studies on its usage in children. We report herein two children of condyloma acuminata cases that have responded dramatically to topically applied imiquimod.

Özet

İmikimod eksternal anogenital verrülerin topikal tedavisinde etkinliği bildirilmiş ve kullanımı onaylanmış immün modülatör bir ajandır. Ancak küçük çocuklarda kullanımıyla ilgili çok az sayıda çalışma mevcuttur. Bu bildiride iki küçük çocuk hastada topikal imiquimod uygulamasına kısa sürede dramatik yanıt alınan kondiloma aküminata olguları sunulmaktadır.

🔖

Cite This Article

TUNCEL, A. A., ERBAĞCI, Z. (2022). Dramatic response of the topical imiquimod treatment in genital warts: Two children cases. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 40 - Sayı: 4, 142–144. https://ajindex.com/articles/622165

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Severson J, Evans TY, Lee P, et al: Human papillomavirus infections: Epidemiology, pathogenesis, and therapy. J Cutan Med Surg 2001;5:43-60
  2. Gunter J: Genital and perianal warts: New treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol 2003;189:S3-S11
  3. Moscicki A: Genital human papillomavirus infections in children and adolescents. Curr Probl Dermatol 2000;12:134-40
  4. Edwards L, Ferenczy A, Eron L, et al: Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30
  5. Berman B, Poochareon VN, Villa AM: Novel dermatologic uses of the immune response modifier imiquimod 5% cream. Skin Therapy Lett 2002;7:1-6
  6. Hengge UR, Esser S, et al: Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 2000; 143:1026-31
  7. Onsun N, Ufacık H, Kural Y, Topçu E, Somay A: Efficacy of imiquimod in solitary plaques of mycosis fungoides. J Eur Acad Dermatol Venereol 2004;18(Suppl 2):S22 (Abstract)
  8. Gruber PC, Wilkinson J: Successful treatment of perianal warts in a child with 5% imiquimod cream. J Dermatolog Treat 2001;12:215-7
  9. Majewski S, Pniewski T, Malejczyk M et al: Imiquimod is highly effective for extensive, hyperproliferative condyloma in children. Pediatr Dermatol 2003;20: 440-2
  10. Grussendorf-Conen El, Jacobs S, Jacobs S: Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol 2002;19:263-6
  11. Schaen L, Mercurio MG: Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream. Pediatr Dermatol 2001;18:450-2
  12. Moresi JM, Herbert CR, Cohen BA. Treatment of Anogenital Warts in Children with Topical 0.05% Podofilox Gel and 5% Imiquimod Cream. Pediatr Dermatol 2001; 18: 448-50; discussion 452
  13. Lowy DR, Androphy EJ: Warts. Fitzpatrick's Dermatology in General Medicine'de. Ed. Freedberg İM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI
  14. Baskı. New York, McGraw-Hill, 2003;2119-31
  15. Tyring SK: Human papilloma virus infections: Epidemiology, pathogenesis, and host immune response. J Am Acad Dermatol 2000;43:S 18-26
  16. Hornor G: Ano-genital warts in children: sexual abuse or not? J Pediatr Health Care 2004;18:165-70
  17. Hurwitz DJ, Pincus L et al: Imiquimod a topically applied link between innate and acquired immunity. Arch Dermatol 2003;139:1349-50
  18. Tyring S, Conant M, Marini M: Imiquimod; an international update on therapeutic uses in